<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-B/A
FOR REGISTRATION OF SECURITIES OF CERTAIN
SUCCESSOR ISSUERS
Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934
Mycogen Corporation
-------------------
(Exact name of registrant as specified in its charter)
California 0-15881 95-3802654
---------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5501 Oberlin Drive, San Diego California, 92121
-----------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: 619-453-8030
Not Applicable
--------------
(Former name or former address, if changed since last report.)
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH
TO BE SO REGISTERED EACH CLASS IS TO BE REGISTERED
-------------------- -------------------------------
NONE
- ------------------------------ -------------------------------
- ------------------------------ -------------------------------
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
PREFERRED SHARE PURCHASE RIGHTS
-------------------------------
(Title of Class)
1
<PAGE>
ITEMS 1. - 6. Items 1 through 6 from the Form 8-B filed by the Registrant
on February 13, 1996, are hereby incorporated by this reference. All provisions
of the Rights Agreement as defined in such Form 8-B remain the same except that
Amendment No. 1 to Amended and Restated Rights Agreement, dated February 20,
1996, deleted all references in the Rights Agreement to the Lubrizol
Corporation.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Not applicable.
(b) Not applicable.
(c) Exhibits: The following Exhibit is filed as part of this Form 8-B:
---------
Exhibit Number Description
-------------- -----------
4.1 Amendment No. 1 to Amended and Restated Rights
Agreement/1/
/1/ Previously filed as an exhibit to the Company's Form 8-K filed on March 22,
1996, and incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Mycogen Corporation
-------------------
(Registrant)
Date: March 22, 1996, /s/ James A. Baumker
--------------- ----------------------
James A. Baumker
Vice President,
Chief Financial Officer,
Chief Accounting Officer
2
